drugset / Trial / NCT02696564
Losartan Effects on Emphysema Progression
RandomizedParallel-groupTriple-blindTreatment
Summary
A randomized, parallel, placebo controlled trial to evaluate the effect of 100mg/day losartan on the progression of emphysema as measured by quantitative HRCT compared to placebo .
Timeline
- Start
- 2017-05-23
- Primary completion
- 2021-03-31
- Completion
- 2021-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Losartan | Other / unclassified | 100 mg | — |